CHS 8% Cumulative Redeemable Pfd (CHSCP) Financials

CHSCP NASDAQ

Trailing 12 months to May 31, 2026

Revenue $37.4B +3.8% YoY

Net Income $577.5M +12.6% YoY

Free Cash Flow $932.9M n/m YoY

Operating Cash Flow $1.5B +208.1% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended May 31, 2026 Reported Jul 8, 2026 Currency USD FYE August

Newest figures come from the 10-Q for Q3 FY2026, filed Jul 8, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CHSCP SEC filings page.

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) reported $37.4B in revenue over the twelve months to May 31, 2026, up 3.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CHSCP FY2025 2026-10-24

CHS Inc.’s recent downturn has squeezed margins and cash generation, while a less leveraged balance sheet absorbs much of the pressure.

The non-obvious shift is that FY2025 net income of $598M still produced operating cash flow of $636M, so accounting earnings remained cash-backed. Yet capital expenditures consumed 114.6% of operating cash flow, turning that positive operating cash into free cash flow of -$93M and making reinvestment the immediate cash constraint.

From FY2023 to FY2025, revenue fell 22.2% while gross profit fell 52.2%, showing that the downturn hit business economics harder than scale alone would suggest. Operating margin then compressed from 2.9% to 0.3%, leaving a much thinner profit cushion after operating costs.

FY2025’s balance sheet became less debt-dependent: total liabilities declined 8.5% from FY2023 while equity increased 6.0%, even as earnings weakened. Debt-to-equity was 0.2x and current ratio was 1.5x, indicating modest financial leverage and a positive, though not excessive, short-term coverage position.

Financial Health Signals

Financial Health Score 33/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of CHS Inc. 8% Cumulative Redeemable Pfd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

CHS Inc. 8% Cumulative Redeemable Pfd has an operating margin of 0.3%, meaning the company retains less than $1 of operating profit per $100 of revenue. This results in a moderate score of 39/100, indicating healthy but not exceptional operating efficiency. This is down from 1.5% the prior year.

Growth

CHS Inc. 8% Cumulative Redeemable Pfd's revenue declined 9.7% year-over-year, from $39.3B to $35.5B. This contraction results in a growth score of 8/100.

Leverage

CHS Inc. 8% Cumulative Redeemable Pfd has a moderate D/E ratio of 0.16. This balance of debt and equity financing earns a leverage score of 32/100.

Liquidity

CHS Inc. 8% Cumulative Redeemable Pfd's current ratio of 1.53 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While CHS Inc. 8% Cumulative Redeemable Pfd generated $635.8M in operating cash flow, capex of $728.6M consumed most of it, leaving -$92.8M in free cash flow. This results in a low score of 31/100, reflecting heavy capital investment rather than weak cash generation.

Returns

CHS Inc. 8% Cumulative Redeemable Pfd's ROE of 5.4% shows moderate profitability relative to equity, earning a score of 44/100. This is down from 10.3% the prior year.

Piotroski F-Score Partial

4/8

CHS Inc. 8% Cumulative Redeemable Pfd passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.06x

For every $1 of reported earnings, CHS Inc. 8% Cumulative Redeemable Pfd generates $1.06 in operating cash flow ($635.8M OCF vs $597.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

0.62x

CHS Inc. 8% Cumulative Redeemable Pfd earns $0.62 in operating income for every $1 of interest expense ($90.8M vs $146.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.6B

YoY+18.6%

QoQ+38.6%

5Y CAGR+1.2%

10Y CAGR+4.0%

CHS Inc. 8% Cumulative Redeemable Pfd generated $11.6B in revenue in Q3 2026. This represents an increase of 18.6% from the same quarter a year earlier. Against the prior quarter it is up 38.6%.

EBITDA

$273.7M

YoY+18.8%

QoQn/m

5Y CAGR+0.9%

10Y CAGR+0.3%

CHS Inc. 8% Cumulative Redeemable Pfd's EBITDA was $273.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 18.8% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income

$267.4M

YoY+15.2%

QoQn/m

5Y CAGR-0.5%

10Y CAGR+3.5%

CHS Inc. 8% Cumulative Redeemable Pfd reported $267.4M in net income in Q3 2026. This represents an increase of 15.2% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow

$984.7M

YoY+89.1%

QoQn/m

5Y CAGR+18.1%

10Y CAGRn/m

CHS Inc. 8% Cumulative Redeemable Pfd generated $984.7M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 89.1% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$497.6M

YoY+53.7%

QoQ+100.3%

5Y CAGR+10.6%

10Y CAGR+3.7%

CHS Inc. 8% Cumulative Redeemable Pfd held $497.6M in cash against $2.0B in long-term debt as of Q3 2026.

Shares Outstanding

YoYn/m

QoQn/m

5Y CAGRn/m

10Y CAGRn/m

CHS Inc. 8% Cumulative Redeemable Pfd had 0 shares outstanding in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

3.5%

YoY+0.2pp

QoQ+3.2pp

5Y change+0.7pp

10Y change-0.5pp

CHS Inc. 8% Cumulative Redeemable Pfd's gross margin was 3.5% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.2 percentage points.

Operating Margin

0.9%

YoY+0.2pp

QoQ+3.8pp

5Y change-0.2pp

10Y change-1.0pp

CHS Inc. 8% Cumulative Redeemable Pfd's operating margin was 0.9% in Q3 2026, reflecting core business profitability. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Net Margin

2.3%

YoY-0.1pp

QoQ+4.1pp

5Y change-0.2pp

10Y change-0.1pp

CHS Inc. 8% Cumulative Redeemable Pfd's net profit margin was 2.3% in Q3 2026, showing the share of revenue converted to profit. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.1 percentage points.

Return on Equity

2.4%

YoY+0.2pp

QoQ+3.7pp

5Y change-0.7pp

10Y change0.0pp

CHS Inc. 8% Cumulative Redeemable Pfd's quarterly ROE was 2.4% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.7 percentage points.

Capital Allocation

Capital Expenditures

$123.3M

YoY-29.9%

QoQ+17.5%

5Y CAGR+10.7%

10Y CAGR-0.5%

CHS Inc. 8% Cumulative Redeemable Pfd invested $123.3M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 29.9% from the same quarter a year earlier. Against the prior quarter it is up 17.5%.

R&D Spending

Not reported for Q3 2026.

Share Buybacks

Not reported for Q3 2026.

CHSCP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CHSCP quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$37.4B	$35.5B-9.7%	$39.3B-13.9%	$45.6B-4.6%	$47.8B+24.3%	$38.4B+35.4%	$28.4B-11.0%	$31.9B-2.4%	$32.7B+2.0%	$32.0B+5.5%	$30.4B-12.2%	$34.6B-18.9%	$42.7B-4.1%	$44.5B+9.6%	$40.6B+10.0%	$36.9B
Cost of Revenue	$36.3B	$34.3B-8.5%	$37.5B-13.2%	$43.2B-5.4%	$45.7B+21.8%	$37.5B+36.7%	$27.4B-10.1%	$30.5B-3.4%	$31.6B+1.4%	$31.1B+6.0%	$29.4B-11.2%	$33.1B-19.3%	$41.0B-4.0%	$42.7B+10.7%	$38.6B+8.7%	$35.5B
Gross Profit	$1.2B	$1.1B-35.1%	$1.8B-26.3%	$2.4B+11.7%	$2.1B+123.6%	$951.4M-3.1%	$981.8M-29.1%	$1.4B+26.8%	$1.1B+22.2%	$893.9M-7.7%	$968.7M-35.0%	$1.5B-9.8%	$1.7B-7.1%	$1.8B-11.6%	$2.0B+43.4%	$1.4B
SG&A Expenses	$1.1B	$1.0B-10.4%	$1.2B+13.0%	$1.0B+3.5%	$997.8M+33.8%	$745.6M+5.8%	$704.5M-2.8%	$724.7M+13.3%	$639.8M+4.7%	$611.1M+1.6%	$601.3M-6.4%	$642.3M+6.6%	$602.6M+8.8%	$553.6M+11.1%	$498.2M+13.6%	$438.5M
Operating Income	$41.7M	$90.8M-84.5%	$584.4M-56.5%	$1.3B+19.0%	$1.1B+448.6%	$205.8M-25.8%	$277.3M-58.0%	$659.6M+45.8%	$452.4Mn/m	-$173.9M-159.5%	$292.4M-59.1%	$715.4M-31.9%	$1.0B-14.3%	$1.2B-19.0%	$1.5B+56.9%	$964.3M
EBITDA	N/A	$742.2M-35.7%	$1.2B-38.7%	$1.9B+18.4%	$1.6B+138.4%	$667.5M-11.5%	$754.6M-33.4%	$1.1B+21.8%	$930.4M+203.7%	$306.3M-58.6%	$739.9M-30.9%	$1.1B-21.0%	$1.4B-9.7%	$1.5B-13.3%	$1.7B+46.2%	$1.2B
Interest Expense	$179.9M	$146.1M+40.4%	$104.1M-24.3%	$137.4M+20.4%	$114.2M+9.2%	$104.6M-10.6%	$117.0M-30.0%	$167.1M+12.0%	$149.2M-12.9%	$171.2M+50.6%	$113.7M+60.9%	$70.7M-16.8%	$84.9M-14.5%	$99.3M+5.5%	$94.1M+13.3%	$83.0M
Income Tax	-$6.3M	$16.8Mn/m	-$4.9M-104.5%	$107.7M-18.5%	$132.1Mn/m	-$38.2Mn/m	-$36.7Mn/m	-$12.5Mn/m	-$104.1Mn/m	-$181.1M-1048.3%	$19.1Mn/m	-$12.2M-125.2%	$48.3M-46.1%	$89.7M+10.9%	$80.9M-6.7%	$86.6M
Net Income	$577.5M	$597.9M-45.8%	$1.1B-42.0%	$1.9B+13.2%	$1.7B+203.1%	$554.0M+31.1%	$422.4M-49.1%	$829.9M+7.0%	$775.9M+983.8%	$71.6M-81.3%	$383.2M-50.9%	$781.0M-27.8%	$1.1B+9.0%	$992.4M-21.3%	$1.3B+31.1%	$961.4M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$11.6B+18.6%	$8.4B+7.2%	$8.9B-4.6%	$8.6B-6.2%	$9.8B+1.6%	$7.8B-14.2%	$9.3B-18.4%	$9.2B-3.3%
Cost of Revenue	$11.2B+18.4%	$8.3B+7.9%	$8.5B-4.7%	$8.3B-7.0%	$9.4B+3.2%	$7.7B-11.5%	$8.9B-17.2%	$8.9B-1.7%
Gross Profit	$410.6M+24.5%	$25.8M-66.2%	$389.4M-2.8%	$330.0M+21.0%	$329.8M-29.5%	$76.3M-79.1%	$400.7M-37.9%	$272.7M-37.8%
SG&A Expenses	$302.3M+16.8%	$267.6M+7.8%	$268.1M+2.0%	$276.1M-8.0%	$258.9M-18.2%	$248.3M-16.8%	$262.9M+4.3%	$300.2M+6.1%
Operating Income	$108.3M+52.7%	-$241.8Mn/m	$121.2M-12.0%	$53.9Mn/m	$71.0M-53.1%	-$172.0M-354.1%	$137.8M-64.9%	-$27.6M-117.7%
EBITDA	$273.7M+18.8%	-$69.2Mn/m	$292.1M+2.3%	$243.3M+101.7%	$230.3M-21.9%	-$16.9M-108.1%	$285.5M-46.2%	$120.6M-59.1%
Interest Expense	$49.7M+12.7%	$43.8M+73.6%	$37.4M+35.1%	$49.1M+92.2%	$44.1M+88.3%	$25.2M-1.0%	$27.6M-6.7%	$25.6M-18.3%
Income Tax	$14.7M-45.8%	-$17.8Mn/m	$11.7M-11.4%	-$14.9Mn/m	$27.2M+115.5%	-$8.7M-156.8%	$13.2Mn/m	-$26.3M-163.6%
Net Income	$267.4M+15.2%	-$147.1Mn/m	$260.5M+6.4%	$196.7M+75.9%	$232.2M-21.9%	-$75.8M-144.5%	$244.8M-53.2%	$111.8M-59.8%

Not reported in any period shown, so not listed: R&D Expenses, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

CHSCP Balance Sheet

CHSCP quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$18.9B+0.8%	$18.7B-1.3%	$19.0B+0.7%	$18.8B+7.1%	$17.6B+9.9%	$16.0B-2.8%	$16.4B+0.4%	$16.4B+3.6%	$15.8B-8.6%	$17.3B+13.7%	$15.2B-0.4%	$15.3B+13.3%	$13.5B-1.0%	$13.6B+11.7%	$12.2B
Current Assets	$8.1B-7.1%	$8.7B-4.6%	$9.1B-2.7%	$9.4B+17.2%	$8.0B+27.6%	$6.3B-5.9%	$6.7B-0.5%	$6.7B+18.9%	$5.6B-18.8%	$6.9B-13.4%	$8.0B-14.8%	$9.4B+5.5%	$8.9B-7.8%	$9.7B+10.6%	$8.7B
Cash & Equivalents	$327.8M-58.8%	$794.9M-55.0%	$1.8B+122.3%	$794.0M+92.2%	$413.2M+193.3%	$140.9M-33.3%	$211.2M-53.1%	$450.6M+148.4%	$181.4M-37.5%	$290.3M-70.0%	$967.7M-54.6%	$2.1B+18.0%	$1.8B+475.9%	$314.0M-66.5%	$937.7M
Short-Term Investments	$0-100.0%	$500.9Mn/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$3.3B+6.6%	$3.1B-4.6%	$3.2B-12.0%	$3.7B+9.5%	$3.3B+21.6%	$2.7B-3.9%	$2.9B+3.1%	$2.8B+6.4%	$2.6B+9.7%	$2.4B-10.6%	$2.7B-3.9%	$2.8B+3.6%	$2.7B	N/A	N/A
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$239.4M+33.0%	$180.0M0.0%	$180.0M0.0%	$180.0M+4.9%	$171.6M-0.5%	$172.4M0.0%	$172.4M+24.5%	$138.5M0.0%	$138.5M-4.0%	$144.3M-3.9%	$150.1M-5.4%	$158.7M+86.6%	$85.1M+4.1%	$81.7M+209.3%	$26.4M
Total Liabilities	$7.8B-2.2%	$8.0B-6.5%	$8.5B-9.2%	$9.4B+9.4%	$8.6B+19.3%	$7.2B-8.3%	$7.8B-4.7%	$8.2B+1.2%	$8.1B-14.1%	$9.5B+25.0%	$7.6B-14.4%	$8.8B+5.7%	$8.4B-8.9%	$9.2B+18.4%	$7.8B
Current Liabilities	$5.3B-2.2%	$5.4B-8.4%	$5.9B-15.1%	$7.0B+9.9%	$6.3B+28.6%	$4.9B-11.9%	$5.6B-5.9%	$5.9B+8.2%	$5.5B-15.9%	$6.5B+24.0%	$5.3B-15.6%	$6.2B+7.7%	$5.8B-15.2%	$6.8B+14.4%	$6.0B
Non-Current Liabilities	$2.5B-2.1%	$2.6B-2.0%	$2.6B+8.0%	$2.4B+7.8%	$2.2B-1.0%	$2.3B+0.5%	$2.3B-1.6%	$2.3B-13.3%	$2.6B-10.1%	$2.9B+27.0%	$2.3B-11.6%	$2.6B+1.2%	$2.6B+9.1%	$2.4B+31.7%	$1.8B
Long-Term Debt	$1.7B-4.3%	$1.8B+0.2%	$1.8B+9.1%	$1.7B+5.6%	$1.6B-1.4%	$1.6B-8.5%	$1.7B-0.7%	$1.8B-12.9%	$2.0B-2.9%	$2.1B+65.2%	$1.3B-10.2%	$1.4B-3.2%	$1.5B+8.9%	$1.3B-5.6%	$1.4B
Total Equity	$11.1B+3.0%	$10.8B+2.9%	$10.4B+10.5%	$9.5B+5.0%	$9.0B+2.3%	$8.8B+2.3%	$8.6B+5.6%	$8.2B+6.0%	$7.7B-2.0%	$7.9B+2.5%	$7.7B+18.8%	$6.4B+25.7%	$5.1B+15.2%	$4.5B0.0%	$4.5B
Retained Earnings	$3.0B+7.5%	$2.8B+10.6%	$2.5B+23.4%	$2.1B+19.9%	$1.7B+5.9%	$1.6B+2.1%	$1.6B+6.9%	$1.5B+16.9%	$1.3B-19.9%	$1.6B+6.5%	$1.5B-7.1%	$1.6B+15.8%	$1.4B	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$20.8B+5.5%	$20.9B+4.0%	$20.7B+6.0%	$18.9B+0.8%	$19.7B+6.7%	$20.1B+4.9%	$19.6B-4.2%	$18.7B-1.3%
Current Assets	$9.9B+11.4%	$10.3B+5.8%	$9.9B+5.8%	$8.1B-7.1%	$8.9B+5.5%	$9.7B+4.0%	$9.4B-11.6%	$8.7B-4.6%
Cash & Equivalents	$497.6M+53.7%	$248.5M-42.7%	$374.7M-16.8%	$327.8M-58.8%	$323.9M+4.4%	$433.3M-31.6%	$450.5M-66.6%	$794.9M-55.0%
Short-Term Investments	$0n/m	$0n/m	$0-100.0%	$0-100.0%	$0n/m	$0n/m	$345.2Mn/m	$500.9Mn/m
Inventory	$3.6B+4.5%	$4.9B+5.2%	$4.3B+10.9%	$3.3B+6.6%	$3.5B+4.4%	$4.6B+18.1%	$3.9B-8.2%	$3.1B-4.6%
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	N/A	N/A	N/A	$239.4M+33.0%	N/A	N/A	N/A	$180.0M0.0%
Total Liabilities	$9.6B+7.6%	$9.9B+4.9%	$9.5B+8.9%	$7.8B-2.2%	$8.9B+17.9%	$9.4B+11.8%	$8.8B-10.0%	$8.0B-6.5%
Current Liabilities	$6.8B+6.5%	$7.1B+4.4%	$7.0B+14.8%	$5.3B-2.2%	$6.4B+22.1%	$6.8B+14.8%	$6.1B-12.9%	$5.4B-8.4%
Non-Current Liabilities	$2.8B+10.3%	$2.8B+6.2%	$2.6B-4.5%	$2.5B-2.1%	$2.5B+8.6%	$2.6B+4.5%	$2.7B-2.9%	$2.6B-2.0%
Long-Term Debt	$2.0B+8.6%	$2.0B+8.5%	$1.7B-4.5%	$1.7B-4.3%	$1.8B+9.4%	$1.8B+9.4%	$1.8B+0.2%	$1.8B+0.2%
Total Equity	$11.2B+3.9%	$11.1B+3.2%	$11.2B+3.6%	$11.1B+3.0%	$10.8B-1.1%	$10.7B-0.5%	$10.8B+1.1%	$10.8B+2.9%
Retained Earnings	$3.2B+5.1%	$3.0B+5.3%	$3.2B+8.3%	$3.0B+7.5%	$3.0B-5.1%	$2.8B-4.8%	$2.9B+1.3%	$2.8B+10.6%

Not reported in any period shown, so not listed: Accounts Receivable.

CHSCP Cash Flow Statement

CHSCP quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.5B	$635.8M-50.1%	$1.3B-61.2%	$3.3B+68.7%	$1.9B+156.9%	$757.8M-30.3%	$1.1B-4.6%	$1.1B+6.1%	$1.1B+12.5%	$954.7M-24.3%	$1.3B+121.1%	$570.0M-60.5%	$1.4B-41.7%	$2.5B+244.1%	$718.6M+138.5%	$301.3M
Depreciation & Amortization	N/A	$651.4M+14.3%	$569.9M+5.6%	$539.5M+16.8%	$462.0M+0.1%	$461.7M-3.3%	$477.4M+0.9%	$473.2M-1.0%	$478.1M-0.5%	$480.2M+7.3%	$447.5M+25.9%	$355.4M+16.1%	$306.2M+10.7%	$276.6M+25.9%	$219.6M-0.5%	$220.7M
Capital Expenditures	$539.4M	$728.6M-9.9%	$808.8M+43.3%	$564.5M+59.3%	$354.4M+11.5%	$317.8M-24.0%	$418.4M-5.6%	$443.2M+24.7%	$355.4M-20.0%	$444.4M-35.9%	$692.8M-41.6%	$1.2B+29.1%	$919.1M+48.3%	$619.9M+32.3%	$468.6M+50.8%	$310.7M
Free Cash Flow	$932.9M	-$92.8M-120.0%	$464.1M-82.9%	$2.7B+70.8%	$1.6B+261.8%	$440.0M-34.2%	$668.9M-4.0%	$696.7M-3.1%	$719.1M+40.9%	$510.3M-10.1%	$567.8Mn/m	-$616.8M-218.1%	$522.2M-71.8%	$1.9B+641.2%	$250.0Mn/m	-$9.3M
Investing Cash Flow	-$832.1M	-$880.6Mn/m	-$1.4Bn/m	-$950.2Mn/m	-$457.1Mn/m	-$101.7Mn/m	-$243.7Mn/m	-$661.3Mn/m	-$79.5Mn/m	-$405.0Mn/m	-$3.7Bn/m	-$1.9Bn/m	-$1.3Bn/m	-$495.3Mn/m	-$694.2Mn/m	-$551.0M
Financing Cash Flow	-$444.2M	-$230.6Mn/m	-$814.3Mn/m	-$1.4Bn/m	-$1.1Bn/m	-$326.6Mn/m	-$931.1Mn/m	-$725.6Mn/m	-$732.2Mn/m	-$618.3M-134.1%	$1.8B+1079.4%	$153.8M-23.6%	$201.4Mn/m	-$478.0Mn/m	-$638.9M-181.2%	$786.9M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$1.1B+59.1%	-$569.0Mn/m	-$337.8Mn/m	$1.3B+14.2%	$696.6M+25.1%	-$1.0Bn/m	-$294.0Mn/m	$1.1B-15.3%
Depreciation & Amortization	$165.3M+3.7%	$172.6M+11.4%	$170.8M+15.7%	$189.3M+27.8%	$159.4M+11.1%	$155.0M+10.6%	$147.7M+7.0%	$148.2M+131.0%
Capital Expenditures	$123.3M-29.9%	$105.0M-36.4%	$116.0M-39.8%	$195.1M-27.0%	$175.9M-9.9%	$164.9M-19.0%	$192.7M+35.3%	$267.4M+40.5%
Free Cash Flow	$984.7M+89.1%	-$674.0Mn/m	-$453.8Mn/m	$1.1B+27.2%	$520.6M+44.0%	-$1.2Bn/m	-$486.6Mn/m	$845.8M-24.8%
Investing Cash Flow	-$298.4Mn/m	$42.6Mn/m	-$247.9Mn/m	-$328.4Mn/m	-$506.3Mn/m	-$39.2Mn/m	-$6.7Mn/m	-$912.1Mn/m
Financing Cash Flow	-$525.2Mn/m	$392.1M-63.3%	$644.2Mn/m	-$955.3M-439.6%	-$307.5Mn/m	$1.1Bn/m	-$36.0Mn/m	$281.3Mn/m

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

CHSCP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CHSCP quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	3.2%-1.3pp	4.5%-0.8pp	5.2%+0.8pp	4.5%+2.0pp	2.5%-1.0pp	3.5%-0.9pp	4.3%+1.0pp	3.3%+0.5pp	2.8%-0.4pp	3.2%-1.1pp	4.3%+0.4pp	3.9%-0.1pp	4.0%-1.0pp	5.0%+1.2pp	3.8%
Operating Margin	0.3%-1.2pp	1.5%-1.5pp	2.9%+0.6pp	2.4%+1.8pp	0.5%-0.4pp	1.0%-1.1pp	2.1%+0.7pp	1.4%+1.9pp	-0.5%-1.5pp	1.0%-1.1pp	2.1%-0.4pp	2.5%-0.3pp	2.8%-1.0pp	3.7%+1.1pp	2.6%
Net Margin	1.7%-1.1pp	2.8%-1.4pp	4.2%+0.7pp	3.5%+2.1pp	1.4%-0.1pp	1.5%-1.1pp	2.6%+0.2pp	2.4%+2.1pp	0.2%-1.0pp	1.3%-1.0pp	2.3%-0.3pp	2.5%+0.3pp	2.2%-0.9pp	3.1%+0.5pp	2.6%
Return on Equity	5.4%-4.8pp	10.3%-7.9pp	18.2%+0.4pp	17.8%+11.6pp	6.2%+1.3pp	4.8%-4.8pp	9.6%+0.1pp	9.5%+8.6pp	0.9%-4.0pp	4.9%-5.3pp	10.2%-6.6pp	16.8%-2.6pp	19.3%-8.9pp	28.3%+6.7pp	21.6%
Return on Assets	3.2%-2.7pp	5.9%-4.1pp	10.0%+1.1pp	8.9%+5.8pp	3.1%+0.5pp	2.6%-2.4pp	5.1%+0.3pp	4.7%+4.3pp	0.4%-1.8pp	2.2%-2.9pp	5.1%-1.9pp	7.1%-0.3pp	7.3%-1.9pp	9.2%+1.4pp	7.9%
Current Ratio	1.53-0.1x	1.61+0.1x	1.55+0.2x	1.35+0.1x	1.260.0x	1.27+0.1x	1.19+0.1x	1.13+0.1x	1.030.0x	1.06-0.5x	1.520.0x	1.510.0x	1.54+0.1x	1.420.0x	1.47
Debt-to-Equity	0.160.0x	0.170.0x	0.170.0x	0.180.0x	0.180.0x	0.180.0x	0.200.0x	0.220.0x	0.260.0x	0.27+0.1x	0.16-0.1x	0.22-0.1x	0.280.0x	0.300.0x	0.32
Liabilities-to-Equity	0.700.0x	0.74-0.1x	0.81-0.2x	0.990.0x	0.95+0.1x	0.82-0.1x	0.91-0.1x	1.010.0x	1.06-0.1x	1.20+0.2x	0.99-0.4x	1.37-0.3x	1.63-0.4x	2.06+0.3x	1.74
Asset Turnover	1.88-0.2x	2.10-0.3x	2.40-0.1x	2.54+0.4x	2.19+0.4x	1.78-0.2x	1.94-0.1x	2.000.0x	2.03+0.3x	1.75-0.5x	2.27-0.5x	2.79-0.5x	3.29+0.3x	2.980.0x	3.02
FCF Margin	-0.3%-1.4pp	1.2%-4.8pp	6.0%+2.6pp	3.3%+2.2pp	1.1%-1.2pp	2.4%+0.2pp	2.2%0.0pp	2.2%+0.6pp	1.6%-0.3pp	1.9%+3.7pp	-1.8%-3.0pp	1.2%-2.9pp	4.2%+3.6pp	0.6%+0.7pp	0.0%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	3.5%+0.2pp	0.3%-0.7pp	4.4%+0.1pp	3.8%+0.9pp	3.4%-1.5pp	1.0%-3.1pp	4.3%-1.3pp	3.0%-1.6pp
Operating Margin	0.9%+0.2pp	-2.9%-0.7pp	1.4%-0.1pp	0.6%+0.9pp	0.7%-0.9pp	-2.2%-3.0pp	1.5%-2.0pp	-0.3%-1.9pp
Net Margin	2.3%-0.1pp	-1.8%-0.8pp	2.9%+0.3pp	2.3%+1.1pp	2.4%-0.7pp	-1.0%-2.8pp	2.6%-2.0pp	1.2%-1.7pp
Return on Equity	2.4%+0.2pp	-1.3%-0.6pp	2.3%+0.1pp	1.8%+0.7pp	2.1%-0.6pp	-0.7%-2.3pp	2.3%-2.6pp	1.0%-1.6pp
Return on Assets	1.3%+0.1pp	-0.7%-0.3pp	1.3%0.0pp	1.0%+0.4pp	1.2%-0.4pp	-0.4%-1.3pp	1.3%-1.3pp	0.6%-0.9pp
Current Ratio	1.47+0.1x	1.450.0x	1.42-0.1x	1.53-0.1x	1.40-0.2x	1.43-0.1x	1.540.0x	1.61+0.1x
Debt-to-Equity	0.180.0x	0.180.0x	0.160.0x	0.160.0x	0.170.0x	0.170.0x	0.170.0x	0.170.0x
Liabilities-to-Equity	0.850.0x	0.890.0x	0.850.0x	0.700.0x	0.83+0.1x	0.88+0.1x	0.81-0.1x	0.74-0.1x
Asset Turnover	0.56+0.1x	0.400.0x	0.430.0x	0.460.0x	0.500.0x	0.39-0.1x	0.47-0.1x	0.490.0x
FCF Margin	8.5%+3.2pp	-8.1%+7.4pp	-5.1%+0.1pp	12.5%+3.3pp	5.3%+1.6pp	-15.4%-10.4pp	-5.2%-2.7pp	9.2%-2.6pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
CHS Inc. 8% Cumulative Redeemable Pfd CHSCP	FY2025	$35.5B	$597.9M	1.7%	N/A	33/100
Forafric Global PLC Warrants AFRIW	FY2025	$176.5M	-$14.9M	-8.4%	N/A	47/100
Edible Garden AG Incorporated Warrant EDBLW	FY2025	$12.8M	-$17.3M	N/A	N/A	38/100
Sadot Group Inc. SDOT	FY2025	N/A	N/A	N/A	$12.9M	—

Where CHS Inc. 8% Cumulative Redeemable Pfd Ranks

Frequently Asked Questions

What is CHS Inc. 8% Cumulative Redeemable Pfd's annual revenue?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) reported $35.5B in total revenue for fiscal year 2025. This represents a -9.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CHS Inc. 8% Cumulative Redeemable Pfd's revenue growing?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) revenue declined by 9.7% year-over-year, from $39.3B to $35.5B in fiscal year 2025.

Is CHS Inc. 8% Cumulative Redeemable Pfd profitable?

Yes, CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) reported a net income of $577.5M over the trailing 12 months to May 31, 2026. In fiscal year 2025 it reported a net income of $597.9M, with a net profit margin of 1.7%.

What is CHS Inc. 8% Cumulative Redeemable Pfd's EBITDA?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had EBITDA of $742.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CHS Inc. 8% Cumulative Redeemable Pfd have?

As of fiscal year 2025, CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had $327.8M in cash and equivalents against $1.7B in long-term debt.

What is CHS Inc. 8% Cumulative Redeemable Pfd's gross margin?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had a gross margin of 3.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is CHS Inc. 8% Cumulative Redeemable Pfd's operating margin?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had an operating margin of 0.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CHS Inc. 8% Cumulative Redeemable Pfd's net profit margin?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had a net profit margin of 1.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is CHS Inc. 8% Cumulative Redeemable Pfd's return on equity (ROE)?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) has a return on equity of 5.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CHS Inc. 8% Cumulative Redeemable Pfd's free cash flow?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) recorded an outflow of $92.8M in free cash flow during fiscal year 2025. This represents a -120.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CHS Inc. 8% Cumulative Redeemable Pfd's operating cash flow?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) generated $635.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CHS Inc. 8% Cumulative Redeemable Pfd's total assets?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had $18.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are CHS Inc. 8% Cumulative Redeemable Pfd's capital expenditures?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) invested $728.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does CHS Inc. 8% Cumulative Redeemable Pfd have outstanding?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had 0 shares outstanding as of fiscal year 2025.

What is CHS Inc. 8% Cumulative Redeemable Pfd's current ratio?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had a current ratio of 1.53 as of fiscal year 2025, which is generally considered healthy.

What is CHS Inc. 8% Cumulative Redeemable Pfd's debt-to-equity ratio?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had a debt-to-equity ratio of 0.16 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is CHS Inc. 8% Cumulative Redeemable Pfd's liabilities-to-equity ratio?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had a liabilities-to-equity ratio of 0.70 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is CHS Inc. 8% Cumulative Redeemable Pfd's return on assets (ROA)?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) had a return on assets of 3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CHS Inc. 8% Cumulative Redeemable Pfd's Piotroski F-Score?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CHS Inc. 8% Cumulative Redeemable Pfd's earnings high quality?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) has an earnings quality ratio of 1.06x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CHS Inc. 8% Cumulative Redeemable Pfd cover its interest payments?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) has an interest coverage ratio of 0.62x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is CHS Inc. 8% Cumulative Redeemable Pfd?

CHS Inc. 8% Cumulative Redeemable Pfd (CHSCP) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.